The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Extracellular Vesicles Based Liquid Biopsy Market Research Report 2025
Synopsis
The global Extracellular Vesicles Based Liquid Biopsy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Extracellular Vesicles Based Liquid Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Extracellular Vesicles Based Liquid Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Extracellular Vesicles Based Liquid Biopsy in Therapeutic Monitoring is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Extracellular Vesicles Based Liquid Biopsy include Bio-Techne, Thermo Fisher Scientific, Qiagen, Exosome Diagnostics, Aethlon Medical, System Biosciences, NanoSomix, Norgen Biotek, Hitachi Chemical, Lonza Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Extracellular Vesicles Based Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracellular Vesicles Based Liquid Biopsy.
The Extracellular Vesicles Based Liquid Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Extracellular Vesicles Based Liquid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracellular Vesicles Based Liquid Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Techne
Thermo Fisher Scientific
Qiagen
Exosome Diagnostics
Aethlon Medical
System Biosciences
NanoSomix
Norgen Biotek
Hitachi Chemical
Lonza Group
Stemcell Technologies
Aruna Bio
Evomic Science
Izon Science
Exovita Biosciences
Segment by Type
Blood-derived Liquid Biopsy
Urine-derived Liquid Biopsy
Saliva-derived Liquid Biopsy
Other
Segment by Application
Therapeutic Monitoring
Medical Diagnostics
Biological Research
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extracellular Vesicles Based Liquid Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Extracellular Vesicles Based Liquid Biopsy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Extracellular Vesicles Based Liquid Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Extracellular Vesicles Based Liquid Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Extracellular Vesicles Based Liquid Biopsy in Therapeutic Monitoring is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Extracellular Vesicles Based Liquid Biopsy include Bio-Techne, Thermo Fisher Scientific, Qiagen, Exosome Diagnostics, Aethlon Medical, System Biosciences, NanoSomix, Norgen Biotek, Hitachi Chemical, Lonza Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Extracellular Vesicles Based Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracellular Vesicles Based Liquid Biopsy.
The Extracellular Vesicles Based Liquid Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Extracellular Vesicles Based Liquid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracellular Vesicles Based Liquid Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Techne
Thermo Fisher Scientific
Qiagen
Exosome Diagnostics
Aethlon Medical
System Biosciences
NanoSomix
Norgen Biotek
Hitachi Chemical
Lonza Group
Stemcell Technologies
Aruna Bio
Evomic Science
Izon Science
Exovita Biosciences
Segment by Type
Blood-derived Liquid Biopsy
Urine-derived Liquid Biopsy
Saliva-derived Liquid Biopsy
Other
Segment by Application
Therapeutic Monitoring
Medical Diagnostics
Biological Research
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extracellular Vesicles Based Liquid Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood-derived Liquid Biopsy
1.2.3 Urine-derived Liquid Biopsy
1.2.4 Saliva-derived Liquid Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Extracellular Vesicles Based Liquid Biopsy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Therapeutic Monitoring
1.3.3 Medical Diagnostics
1.3.4 Biological Research
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extracellular Vesicles Based Liquid Biopsy Market Perspective (2019-2030)
2.2 Global Extracellular Vesicles Based Liquid Biopsy Growth Trends by Region
2.2.1 Global Extracellular Vesicles Based Liquid Biopsy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Extracellular Vesicles Based Liquid Biopsy Historic Market Size by Region (2019-2024)
2.2.3 Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Region (2025-2030)
2.3 Extracellular Vesicles Based Liquid Biopsy Market Dynamics
2.3.1 Extracellular Vesicles Based Liquid Biopsy Industry Trends
2.3.2 Extracellular Vesicles Based Liquid Biopsy Market Drivers
2.3.3 Extracellular Vesicles Based Liquid Biopsy Market Challenges
2.3.4 Extracellular Vesicles Based Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracellular Vesicles Based Liquid Biopsy Players by Revenue
3.1.1 Global Top Extracellular Vesicles Based Liquid Biopsy Players by Revenue (2019-2024)
3.1.2 Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Extracellular Vesicles Based Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Extracellular Vesicles Based Liquid Biopsy Revenue
3.4 Global Extracellular Vesicles Based Liquid Biopsy Market Concentration Ratio
3.4.1 Global Extracellular Vesicles Based Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracellular Vesicles Based Liquid Biopsy Revenue in 2023
3.5 Global Key Players of Extracellular Vesicles Based Liquid Biopsy Head office and Area Served
3.6 Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Product and Application
3.7 Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Extracellular Vesicles Based Liquid Biopsy Breakdown Data by Type
4.1 Global Extracellular Vesicles Based Liquid Biopsy Historic Market Size by Type (2019-2024)
4.2 Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Type (2025-2030)
5 Extracellular Vesicles Based Liquid Biopsy Breakdown Data by Application
5.1 Global Extracellular Vesicles Based Liquid Biopsy Historic Market Size by Application (2019-2024)
5.2 Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Extracellular Vesicles Based Liquid Biopsy Market Size (2019-2030)
6.2 North America Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2019-2024)
6.4 North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extracellular Vesicles Based Liquid Biopsy Market Size (2019-2030)
7.2 Europe Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2019-2024)
7.4 Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size (2019-2030)
8.2 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (2019-2024)
8.4 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Extracellular Vesicles Based Liquid Biopsy Market Size (2019-2030)
9.2 Latin America Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2019-2024)
9.4 Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size (2019-2030)
10.2 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2019-2024)
10.4 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne
11.1.1 Bio-Techne Company Details
11.1.2 Bio-Techne Business Overview
11.1.3 Bio-Techne Extracellular Vesicles Based Liquid Biopsy Introduction
11.1.4 Bio-Techne Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.1.5 Bio-Techne Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Extracellular Vesicles Based Liquid Biopsy Introduction
11.2.4 Thermo Fisher Scientific Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Extracellular Vesicles Based Liquid Biopsy Introduction
11.3.4 Qiagen Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.3.5 Qiagen Recent Development
11.4 Exosome Diagnostics
11.4.1 Exosome Diagnostics Company Details
11.4.2 Exosome Diagnostics Business Overview
11.4.3 Exosome Diagnostics Extracellular Vesicles Based Liquid Biopsy Introduction
11.4.4 Exosome Diagnostics Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.4.5 Exosome Diagnostics Recent Development
11.5 Aethlon Medical
11.5.1 Aethlon Medical Company Details
11.5.2 Aethlon Medical Business Overview
11.5.3 Aethlon Medical Extracellular Vesicles Based Liquid Biopsy Introduction
11.5.4 Aethlon Medical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.5.5 Aethlon Medical Recent Development
11.6 System Biosciences
11.6.1 System Biosciences Company Details
11.6.2 System Biosciences Business Overview
11.6.3 System Biosciences Extracellular Vesicles Based Liquid Biopsy Introduction
11.6.4 System Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.6.5 System Biosciences Recent Development
11.7 NanoSomix
11.7.1 NanoSomix Company Details
11.7.2 NanoSomix Business Overview
11.7.3 NanoSomix Extracellular Vesicles Based Liquid Biopsy Introduction
11.7.4 NanoSomix Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.7.5 NanoSomix Recent Development
11.8 Norgen Biotek
11.8.1 Norgen Biotek Company Details
11.8.2 Norgen Biotek Business Overview
11.8.3 Norgen Biotek Extracellular Vesicles Based Liquid Biopsy Introduction
11.8.4 Norgen Biotek Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.8.5 Norgen Biotek Recent Development
11.9 Hitachi Chemical
11.9.1 Hitachi Chemical Company Details
11.9.2 Hitachi Chemical Business Overview
11.9.3 Hitachi Chemical Extracellular Vesicles Based Liquid Biopsy Introduction
11.9.4 Hitachi Chemical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.9.5 Hitachi Chemical Recent Development
11.10 Lonza Group
11.10.1 Lonza Group Company Details
11.10.2 Lonza Group Business Overview
11.10.3 Lonza Group Extracellular Vesicles Based Liquid Biopsy Introduction
11.10.4 Lonza Group Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.10.5 Lonza Group Recent Development
11.11 Stemcell Technologies
11.11.1 Stemcell Technologies Company Details
11.11.2 Stemcell Technologies Business Overview
11.11.3 Stemcell Technologies Extracellular Vesicles Based Liquid Biopsy Introduction
11.11.4 Stemcell Technologies Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.11.5 Stemcell Technologies Recent Development
11.12 Aruna Bio
11.12.1 Aruna Bio Company Details
11.12.2 Aruna Bio Business Overview
11.12.3 Aruna Bio Extracellular Vesicles Based Liquid Biopsy Introduction
11.12.4 Aruna Bio Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.12.5 Aruna Bio Recent Development
11.13 Evomic Science
11.13.1 Evomic Science Company Details
11.13.2 Evomic Science Business Overview
11.13.3 Evomic Science Extracellular Vesicles Based Liquid Biopsy Introduction
11.13.4 Evomic Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.13.5 Evomic Science Recent Development
11.14 Izon Science
11.14.1 Izon Science Company Details
11.14.2 Izon Science Business Overview
11.14.3 Izon Science Extracellular Vesicles Based Liquid Biopsy Introduction
11.14.4 Izon Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.14.5 Izon Science Recent Development
11.15 Exovita Biosciences
11.15.1 Exovita Biosciences Company Details
11.15.2 Exovita Biosciences Business Overview
11.15.3 Exovita Biosciences Extracellular Vesicles Based Liquid Biopsy Introduction
11.15.4 Exovita Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
11.15.5 Exovita Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Blood-derived Liquid Biopsy
Table 3. Key Players of Urine-derived Liquid Biopsy
Table 4. Key Players of Saliva-derived Liquid Biopsy
Table 5. Key Players of Other
Table 6. Global Extracellular Vesicles Based Liquid Biopsy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Region (2019-2024)
Table 10. Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Region (2025-2030)
Table 12. Extracellular Vesicles Based Liquid Biopsy Market Trends
Table 13. Extracellular Vesicles Based Liquid Biopsy Market Drivers
Table 14. Extracellular Vesicles Based Liquid Biopsy Market Challenges
Table 15. Extracellular Vesicles Based Liquid Biopsy Market Restraints
Table 16. Global Extracellular Vesicles Based Liquid Biopsy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Players (2019-2024)
Table 18. Global Top Extracellular Vesicles Based Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracellular Vesicles Based Liquid Biopsy as of 2023)
Table 19. Ranking of Global Top Extracellular Vesicles Based Liquid Biopsy Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Extracellular Vesicles Based Liquid Biopsy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Headquarters and Area Served
Table 22. Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Product and Application
Table 23. Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Type (2019-2024)
Table 27. Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Type (2025-2030)
Table 29. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Application (2019-2024)
Table 31. Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Application (2025-2030)
Table 33. North America Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2025-2030) & (US$ Million)
Table 48. Bio-Techne Company Details
Table 49. Bio-Techne Business Overview
Table 50. Bio-Techne Extracellular Vesicles Based Liquid Biopsy Product
Table 51. Bio-Techne Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 52. Bio-Techne Recent Development
Table 53. Thermo Fisher Scientific Company Details
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Extracellular Vesicles Based Liquid Biopsy Product
Table 56. Thermo Fisher Scientific Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Qiagen Company Details
Table 59. Qiagen Business Overview
Table 60. Qiagen Extracellular Vesicles Based Liquid Biopsy Product
Table 61. Qiagen Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 62. Qiagen Recent Development
Table 63. Exosome Diagnostics Company Details
Table 64. Exosome Diagnostics Business Overview
Table 65. Exosome Diagnostics Extracellular Vesicles Based Liquid Biopsy Product
Table 66. Exosome Diagnostics Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 67. Exosome Diagnostics Recent Development
Table 68. Aethlon Medical Company Details
Table 69. Aethlon Medical Business Overview
Table 70. Aethlon Medical Extracellular Vesicles Based Liquid Biopsy Product
Table 71. Aethlon Medical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 72. Aethlon Medical Recent Development
Table 73. System Biosciences Company Details
Table 74. System Biosciences Business Overview
Table 75. System Biosciences Extracellular Vesicles Based Liquid Biopsy Product
Table 76. System Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 77. System Biosciences Recent Development
Table 78. NanoSomix Company Details
Table 79. NanoSomix Business Overview
Table 80. NanoSomix Extracellular Vesicles Based Liquid Biopsy Product
Table 81. NanoSomix Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 82. NanoSomix Recent Development
Table 83. Norgen Biotek Company Details
Table 84. Norgen Biotek Business Overview
Table 85. Norgen Biotek Extracellular Vesicles Based Liquid Biopsy Product
Table 86. Norgen Biotek Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 87. Norgen Biotek Recent Development
Table 88. Hitachi Chemical Company Details
Table 89. Hitachi Chemical Business Overview
Table 90. Hitachi Chemical Extracellular Vesicles Based Liquid Biopsy Product
Table 91. Hitachi Chemical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 92. Hitachi Chemical Recent Development
Table 93. Lonza Group Company Details
Table 94. Lonza Group Business Overview
Table 95. Lonza Group Extracellular Vesicles Based Liquid Biopsy Product
Table 96. Lonza Group Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 97. Lonza Group Recent Development
Table 98. Stemcell Technologies Company Details
Table 99. Stemcell Technologies Business Overview
Table 100. Stemcell Technologies Extracellular Vesicles Based Liquid Biopsy Product
Table 101. Stemcell Technologies Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 102. Stemcell Technologies Recent Development
Table 103. Aruna Bio Company Details
Table 104. Aruna Bio Business Overview
Table 105. Aruna Bio Extracellular Vesicles Based Liquid Biopsy Product
Table 106. Aruna Bio Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 107. Aruna Bio Recent Development
Table 108. Evomic Science Company Details
Table 109. Evomic Science Business Overview
Table 110. Evomic Science Extracellular Vesicles Based Liquid Biopsy Product
Table 111. Evomic Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 112. Evomic Science Recent Development
Table 113. Izon Science Company Details
Table 114. Izon Science Business Overview
Table 115. Izon Science Extracellular Vesicles Based Liquid Biopsy Product
Table 116. Izon Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 117. Izon Science Recent Development
Table 118. Exovita Biosciences Company Details
Table 119. Exovita Biosciences Business Overview
Table 120. Exovita Biosciences Extracellular Vesicles Based Liquid Biopsy Product
Table 121. Exovita Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024) & (US$ Million)
Table 122. Exovita Biosciences Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Extracellular Vesicles Based Liquid Biopsy Picture
Figure 2. Global Extracellular Vesicles Based Liquid Biopsy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Type: 2023 VS 2030
Figure 4. Blood-derived Liquid Biopsy Features
Figure 5. Urine-derived Liquid Biopsy Features
Figure 6. Saliva-derived Liquid Biopsy Features
Figure 7. Other Features
Figure 8. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Application: 2023 VS 2030
Figure 10. Therapeutic Monitoring Case Studies
Figure 11. Medical Diagnostics Case Studies
Figure 12. Biological Research Case Studies
Figure 13. Other Case Studies
Figure 14. Extracellular Vesicles Based Liquid Biopsy Report Years Considered
Figure 15. Global Extracellular Vesicles Based Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Extracellular Vesicles Based Liquid Biopsy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Region: 2023 VS 2030
Figure 18. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Players in 2023
Figure 19. Global Top Extracellular Vesicles Based Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracellular Vesicles Based Liquid Biopsy as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Extracellular Vesicles Based Liquid Biopsy Revenue in 2023
Figure 21. North America Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2019-2030)
Figure 23. United States Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2019-2030)
Figure 27. Germany Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Share by Region (2019-2030)
Figure 35. China Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2019-2030)
Figure 43. Mexico Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2019-2030)
Figure 47. Turkey Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. UAE Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Bio-Techne Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 52. Qiagen Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 53. Exosome Diagnostics Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 54. Aethlon Medical Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 55. System Biosciences Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 56. NanoSomix Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 57. Norgen Biotek Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 58. Hitachi Chemical Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 59. Lonza Group Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 60. Stemcell Technologies Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 61. Aruna Bio Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 62. Evomic Science Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 63. Izon Science Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 64. Exovita Biosciences Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
